戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 nza A viruses are a major cause of human and animal disease.
2 s, particularly in species causing human and animal disease.
3 al have been detected in models of human and animal disease.
4 ruses responsible for considerable human and animal disease.
5 igate the role of these viruses in human and animal disease.
6 uses that cause a wide spectrum of human and animal diseases.
7 e unicellular parasites that cause human and animal diseases.
8    NiV and HeV often lead to human death and animal diseases.
9 ed variation in host behaviour when managing animal diseases.
10 otential to impact a wide range of human and animal diseases.
11 ccount for a significant number of human and animal diseases.
12 RNAs has been associated with both human and animal diseases.
13 NA viruses that cause a variety of human and animal diseases.
14 ntribute to a variety of important human and animal diseases.
15 hylum Apicomplexa cause a range of human and animal diseases.
16 n virulence and host resistance in plant and animal diseases.
17 d bases, and ingestion of FB1 causes several animal diseases.
18 function, is implicated in several human and animal diseases, although both betaglycan actions and th
19              Anthrax is a globally important animal disease and zoonosis.
20 ly of parasites that causes lethal human and animal diseases and also serves as a model for studies o
21 ia are responsible for a number of human and animal diseases and are classical intracellular pathogen
22 he major disease signs and lesions of type D animal disease are usually attributed to epsilon toxin,
23                   The control strategies for animal diseases are carried out and financed by livestoc
24 inherited human prion diseases or equivalent animal diseases are poorly understood, in part because c
25 ses are responsible for a range of human and animal diseases, but how their RNA genome is packaged re
26 rotection against many detrimental human and animal diseases, but reversion to virulence by mutation
27    Thus, a biological model for toxicity and animal disease can be assayed using an electrochemical a
28 d-mouth disease (FMD) is a highly contagious animal disease caused by a ribonucleic acid (RNA) virus,
29  of Hispaniola and stored in the Plum Island Animal Disease Center ASFV repository.
30  aeruginosa strains, isolated from companion animal diseases, could be lysed by VL1.
31        The spatial-temporal dynamics of farm animal diseases depend both on disease specific processe
32 are susceptibility test data between aquatic animal disease diagnostic laboratories.
33 osis." A list of major recommended human and animal disease entities (nomenclature) is provided in al
34                   In experimental autoimmune animal diseases, "epitope spreading" seems to have signi
35                    Initially, a USDA Foreign Animal Disease (FAD) investigation confirmed the presenc
36                                              Animal diseases gain political attention by their inclus
37 wth promotion or for treatment or control of animal diseases generates reservoirs of antibiotic-resis
38 uencing crop productivity, yet its impact on animal diseases has been largely overlooked, despite the
39                                    The first animal disease homolog of human Sanfilippo syndrome type
40  most economically important arthropod-borne animal disease in the United States.
41 ns responsible for a wide range of human and animal disease including sepsis, meningitis, urinary tra
42 are etiologic agents of a range of human and animal diseases, including both mild and severe respirat
43 positive pathogen that causes many human and animal diseases, including food poisoning and gas gangre
44 that are responsible for important human and animal diseases, including malaria, toxoplasmosis, crypt
45 ving diagnostic testing for human, plant and animal diseases, including strategies for targeting the
46 factors associated with a range of human and animal diseases, including the pmHAS gene for hyaluronid
47 s are a global vector for multiple human and animal diseases, including West Nile virus, lymphatic fi
48 le of flies in the epidemiology of human and animal diseases is an active area of research, little is
49 -U.S. meat samples tested, in both human and animal diseases is now facilitated by knowledge of their
50 o that of the wild-type parent, the National Animal Disease Laboratory strain of BVDV.
51 ifacient strains followed by selection in an animal disease model and whole-genome sequence analysis.
52 reclinical studies of a DVD-Ig protein in an animal disease model demonstrate its potential for thera
53 omyelitis in mice, a prototypic Th1-mediated animal disease model for multiple sclerosis.
54 logic importance of these interactions in an animal disease model has not been established.
55 amage and improves functional outcomes in an animal disease model in vivo.
56 s disease and representing a norovirus small animal disease model in wild-type mice.
57                       The availability of an animal disease model is essential for understanding path
58 disease incidence and severity in an in vivo animal disease model of multiple sclerosis.
59  has a wide range of applications, including animal disease model phenotyping and the relationships m
60  the behavioral phenotypes of the transgenic animal disease model.
61 been shown to modify the pathobiology in any animal disease model.
62 sments of therapeutic efficacy in this large animal disease model.
63 e variations, for the critical enzymes in an animal disease model.
64  the way for future in vivo studies on small animal disease models (in the mid-term future) and human
65 e demonstrated potent protective activity in animal disease models and are thus promising candidates
66 ne the therapeutic potentials of selenium in animal disease models and in human.
67 transmitters in specific brain structures in animal disease models and in response to drug treatments
68  elucidation of the underlying mechanisms in animal disease models and patient-derived lymphatic endo
69                                              Animal disease models and several ongoing human clinical
70 alysis, to enable faecal host DNA studies in animal disease models as well.
71 Here, the use of different rodent species as animal disease models for REBOV was investigated.
72                                              Animal disease models had revealed the antithetic effect
73         Testing potential drug treatments in animal disease models is a decisive step of all preclini
74 gic and spinal motor neurons in vitro and in animal disease models making them attractive therapeutic
75 ogenesis gained from their identification in animal disease models may impact the treatment of human
76                                Using several animal disease models of COVID-19(6,7), we demonstrate t
77               Thus, organoids may complement animal disease models to accelerate the translation of l
78 dels, this approach can be extended to other animal disease models where macrophages are implicated a
79 ste-immune associative learning with RAPA in animal disease models where mTOR overactivation is one k
80 isualization of genetically labeled cells in animal disease models with micrometer-level resolution w
81 r of glucose-stimulated insulin secretion in animal disease models with no risk of hypoglycemia at th
82 ily, have existing reverse genetics tools or animal disease models, and can be amenable to a platform
83 has been notoriously difficult to restore in animal disease models, but limited data from human trial
84 PK1 inhibition confers resistance in various animal disease models, suggesting that inflammation caus
85 lly relevant doses by oral administration in animal disease models.
86 ing tissue healing and improving outcomes in animal disease models.
87 es in human neuroinflammation and associated animal disease models.
88 porter MA-EBOV for studies of Ebola virus in animal disease models.
89  are studied both in vitro and in vivo using animal disease models.
90 ia-based treatments shown to be effective in animal disease models.
91 hich are observed in psychiatric illness, in animal disease models.
92 eriments, stem-cell differentiation data and animal disease models.
93 ional implications of mechanistic studies in animal disease models.
94 and culminated with the preclinical tests on animal disease models.
95  use for the noninvasive assessment of small animal disease models.
96  therapy has shown great promises in various animal disease models.
97 several have failed despite positive data in animal disease models.
98 ill discuss new data from the study of novel animal disease models.
99 ign viral proteins are protective in several animal disease models.
100  studies of chronic physiological changes in animal disease models.
101 dy dementia, and multiple system atrophy and animal disease models; 2) provide mechanistic insights o
102 cacy of SSOs has been established in various animal disease models; however, the application of SSOs
103  virus (ASFV) is an infectious transboundary animal disease notifiable to the World Organization for
104 ty contribute to multiple forms of human and animal disease on a single plasmid presents further chal
105 pecimens has been used to estimate human and animal disease prevalence.
106 pecimens has been used to estimate human and animal disease prevalence.
107 nd predicted Baseline and Infected states of animal disease progression with accuracy, sensitivity, a
108 ed hosts by chemotherapy, whereas control of animal diseases relies on reducing tsetse populations as
109                 Our results for domesticated animal diseases reveal patterns in the evolution of high
110  can help identify and mitigate zoonotic and animal-disease risks, such as spill-over from animal res
111 s showed that Clostridium perfringens type D animal disease strain CN3718 uses NanI sialidase for adh
112                                 Experimental animal disease studies included murine experimental auto
113 , Parkinson's, and Creutzfeldt-Jakob, and in animal diseases such as BSE.
114 es cause serious, life-threatening human and animal diseases, such as malaria, cryptosporidiosis, tox
115     While these viruses cause many human and animal diseases, such studies leave us with a lesser und
116 ial information for the design of risk-based animal disease surveillance and control strategies.
117 arasites; (ii) building integrated human and animal disease surveillance infrastructure and technical
118                As social fluidity increases, animal-disease systems become increasingly density-depen
119                                Transboundary animal diseases (TADs) represent a persistent and growin
120 major driver for the spread of Transboundary Animal Diseases (TADs).
121 c and public health concerns associated with animal diseases, the study highlights the need for local
122 icomplexan parasites cause serious human and animal diseases, the treatment of which requires identif
123 he oceans to lead to new cures for human and animal disease; the exploitation of natural drugs has al
124  produced in the intestines during human and animal disease, these findings suggest that intestinal p
125 es can persist for years and cause human and animal disease throughout sub-Saharan Africa.
126                             RP was the first animal disease to be globally eradicated in 2011 and is
127              The use of antibiotics to treat animal diseases was followed by the surprising discovery
128 industry is under constant threat of foreign animal diseases, which may emerge without warning due to

 
Page Top